No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DXCM DexCom
- 134.000
- +2.480+1.89%
Close Apr 23 16:00 ET
- 134.000
- 0.0000.00%
Post 19:45 ET
53.07BMarket Cap103.08P/E (TTM)
135.310High131.000Low2.01MVolume131.470Open131.520Pre Close270.20MTurnover0.52%Turnover Ratio103.08P/E (Static)396.03MShares142.00052wk High25.66P/B52.29BFloat Cap74.75052wk Low--Dividend TTM390.22MShs Float164.863Historical High--Div YieldTTM3.28%Amplitude0.340Historical Low134.100Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
Top High Growth Investment Ratio Stocks From Each Sector - GS
Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks Investment Ideas Feature Highlights: Vertiv, Align Technology and DexCom
DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
Comments
Cybersecurity and Dialysis Stocks Soar, Lithium Sinks
After-hours Stock Action
CrowdStrike ( $CrowdStrike(CRWD.US$ ): Cybersecurity Juggernaut
- Post-Earnings Surge: Up over 20% after beating estimates and strong guidance.
- Stellar Performance: Stock up over 130% in the past year, outperforming First Trust Cybersecurity ETF ( $First Trust Exch Traded Fund 2 Nasdaq Cybersecurity Etf(CIBR.US$ ).
Paccar ( $PACCAR Inc(PCAR.US$ ): Record High on Price Target Hike
JPMorgan Boost: Reiterated overwei...
CrowdStrike ( $CrowdStrike(CRWD.US$ ): Cybersecurity Juggernaut
- Post-Earnings Surge: Up over 20% after beating estimates and strong guidance.
- Stellar Performance: Stock up over 130% in the past year, outperforming First Trust Cybersecurity ETF ( $First Trust Exch Traded Fund 2 Nasdaq Cybersecurity Etf(CIBR.US$ ).
Paccar ( $PACCAR Inc(PCAR.US$ ): Record High on Price Target Hike
JPMorgan Boost: Reiterated overwei...
DexCom's start of profitability could signal fast earnings growth, justifying strong share price gains. Despite recent slowdown, the company might continue to execute with prowess.
DexCom's recent profitability and reinvestment are positive signs. The stock's 225% return over five years indicates investors recognize these changes. If maintained, DexCom could have a promising future.
DexCom's high P/S ratio is justified by its superior revenue growth and future prospects. Investors' confidence in the company's future revenues is reflected in this ratio, suggesting the share price won't fall significantly soon.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
mizmo : what program are you using if you don't mind?